SCHEMBL4045671

SCHEMBL4045671

O=C(NC1(C(=O)N2CCC3C2C(=O)CN3S(=O)(=O)C(=O)c2ccccn2)CCCCC1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.33
MAPK14 Q16539 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.33
CTSL P07711 4/20 0.33
CTSS P25774 4/20 0.33
CTSB P07858 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
CTSK P43235 4/20 0.32
USP30 Q70CQ3 2/20 0.32
CHRM4 P08173 1/20 0.32
MMP13 P45452 1/20 0.32
PREP P48147 1/20 0.32
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
FKBP1A P62942 1/20 0.31
TLR7 Q9NYK1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044060 0.89 PLA2G1B (0.40) NPC1RAB9ACTSLCTSSALDH1A1
SCHEMBL4043751 0.89 CTSK (0.40) MAPK14NPC1RAB9AATMCTSL
SCHEMBL4042029 0.88 GPR132 (0.38) NPC1RAB9AKDM4EALDH1A1POLB
SCHEMBL4041513 0.87 CTSK (0.39) RIPK1MAPK14NPC1RAB9AATM
SCHEMBL4041605 0.86 MAPK14 (0.40) MAPK14NPC1RAB9AATMCTSL
SCHEMBL4042382 0.86 HDAC1 (0.35) CTSLCTSSCTSBALDH1A1CTSK
SCHEMBL4041246 0.83 MMP1 (0.38) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL4045068 0.81 MMP3 (0.36) CTSLCTSSCTSBKDM4EALDH1A1
SCHEMBL4043452 0.81 GPR132 (0.42) NPC1RAB9ACHRM4MMP13FKBP1A
SCHEMBL6211206 0.81 CHRM4 (0.32) CTSLCTSSCTSBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP disclosed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed